New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Phase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors

Phase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors

Small molecule inhibitors, such as the investigational CDK9 inhibitor KB-0742, are laying the groundwork for continued research into optimal strategies for targeting the biology of solid tumors, accor
World medicine November 09,2023
Phase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors

Phase 1 Trial Set to Explore Efficacy and Safety of KB-0742 in Solid Tumors

Small molecule inhibitors, such as the investigational CDK9 inhibitor KB-0742, are laying the groundwork for continued research into optimal strategies for targeting the biology of solid tumors, accor
World medicine November 09,2023
Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

A recent article published in theCirculationjournal investigated the interplay among chronic kidney disease, metabolic risk factors, and the cardiovascular system on morbidity and mortalit
World medicine November 09,2023
Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

Presidential advisory by the American Heart Association: connecting cardiovascular, kidney, and metabolic health

A recent article published in theCirculationjournal investigated the interplay among chronic kidney disease, metabolic risk factors, and the cardiovascular system on morbidity and mortalit
World medicine November 09,2023
New AI tool predicts future viral variants using evolutionary, biological information

New AI tool predicts future viral variants using evolutionary, biological information

The COVID-19 pandemic seemed like a never-ending parade of SARS-CoV-2 variants, each equipped with new ways to evade the immune system, leaving the world bracing for what would come next.But what if t
World medicine November 09,2023
New AI tool predicts future viral variants using evolutionary, biological information

New AI tool predicts future viral variants using evolutionary, biological information

The COVID-19 pandemic seemed like a never-ending parade of SARS-CoV-2 variants, each equipped with new ways to evade the immune system, leaving the world bracing for what would come next.But what if t
World medicine November 09,2023
BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

A new research paper was published inOncotarget'sVolume 14 on October 4, 2023, entitled, "Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colore
World medicine November 09,2023
BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

BRAF/EGFR/MEK inhibition suppresses cancer stemness and drug resistance of colorectal cancer cells

A new research paper was published inOncotarget'sVolume 14 on October 4, 2023, entitled, "Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colore
World medicine November 09,2023
Kidney Cancer Study Shows Improved Outcomes for Patients With Advanced Disease When Treated With Belzutifan Over Everolimus

Kidney Cancer Study Shows Improved Outcomes for Patients With Advanced Disease When Treated With Belzutifan Over Everolimus

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibi
World medicine November 09,2023
Kidney Cancer Study Shows Improved Outcomes for Patients With Advanced Disease When Treated With Belzutifan Over Everolimus

Kidney Cancer Study Shows Improved Outcomes for Patients With Advanced Disease When Treated With Belzutifan Over Everolimus

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibi
World medicine November 09,2023
New topical drug shows promise in preventing cutaneous squamous cell carcinoma

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year. While medications exist to prevent the developme
World medicine November 09,2023
New topical drug shows promise in preventing cutaneous squamous cell carcinoma

New topical drug shows promise in preventing cutaneous squamous cell carcinoma

Cutaneous squamous cell carcinoma is the second most common type of skin cancer in the United States, impacting approximately 700,000 people each year. While medications exist to prevent the developme
World medicine November 09,2023
AI helps neurosurgeons identify brain tumor types on the spot

AI helps neurosurgeons identify brain tumor types on the spot

What type of brain tumor does this patient have? AI technology helps to determine this as early as during surgery, within 1.5 hours. This process normally takes a week. The new technology allows neuro
World medicine November 09,2023
AI helps neurosurgeons identify brain tumor types on the spot

AI helps neurosurgeons identify brain tumor types on the spot

What type of brain tumor does this patient have? AI technology helps to determine this as early as during surgery, within 1.5 hours. This process normally takes a week. The new technology allows neuro
World medicine November 09,2023
Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementat
World medicine November 09,2023
Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementat
World medicine November 09,2023
Daylight heals, night light steals: The surprising link between light exposure and mental health

Daylight heals, night light steals: The surprising link between light exposure and mental health

In a recent study published in the journalNature Mental Health, an international team of researchers conducted a large-scale, cross-sectional analysis of sleep, light exposure, mental health, an
World medicine November 09,2023
Daylight heals, night light steals: The surprising link between light exposure and mental health

Daylight heals, night light steals: The surprising link between light exposure and mental health

In a recent study published in the journalNature Mental Health, an international team of researchers conducted a large-scale, cross-sectional analysis of sleep, light exposure, mental health, an
World medicine November 09,2023
Recent Developments in Ovarian and Endometrial Cancers Stir Excitement Among Clinicians

Recent Developments in Ovarian and Endometrial Cancers Stir Excitement Among Clinicians

Despite advanced ovarian and endometrial cancer still being accompanied by a poor prognosis and remaining largely difficult-to-treat diseases, optimism among clinicians has steadily ramped up in recen
World medicine November 09,2023
Recent Developments in Ovarian and Endometrial Cancers Stir Excitement Among Clinicians

Recent Developments in Ovarian and Endometrial Cancers Stir Excitement Among Clinicians

Despite advanced ovarian and endometrial cancer still being accompanied by a poor prognosis and remaining largely difficult-to-treat diseases, optimism among clinicians has steadily ramped up in recen
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com